376 related articles for article (PubMed ID: 31319027)
41. GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo.
Chen Z; Tang J; Wang P; Zhu J; Liu Y
Biomed Res Int; 2019; 2019():5752323. PubMed ID: 31737669
[TBL] [Abstract][Full Text] [Related]
42. Ethanol modulation of intestinal epithelial tight junction barrier.
Ma TY; Nguyen D; Bui V; Nguyen H; Hoa N
Am J Physiol; 1999 Apr; 276(4):G965-74. PubMed ID: 10198341
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression.
Ma TY; Boivin MA; Ye D; Pedram A; Said HM
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G422-30. PubMed ID: 15701621
[TBL] [Abstract][Full Text] [Related]
44. Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model.
Zhao J; Zhao R; Cheng L; Yang J; Zhu L
Dig Liver Dis; 2018 Nov; 50(11):1195-1204. PubMed ID: 29891333
[TBL] [Abstract][Full Text] [Related]
45. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
[TBL] [Abstract][Full Text] [Related]
46. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity.
Weber CR; Raleigh DR; Su L; Shen L; Sullivan EA; Wang Y; Turner JR
J Biol Chem; 2010 Apr; 285(16):12037-46. PubMed ID: 20177070
[TBL] [Abstract][Full Text] [Related]
47. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells.
Yao B; He J; Yin X; Shi Y; Wan J; Tian Z
Toxicol Lett; 2019 Nov; 316():109-118. PubMed ID: 31472180
[TBL] [Abstract][Full Text] [Related]
48. Chlorogenic acid improves the intestinal barrier by relieving endoplasmic reticulum stress and inhibiting ROCK/MLCK signaling pathways.
Song L; Wu T; Zhang L; Wan J; Ruan Z
Food Funct; 2022 Apr; 13(8):4562-4575. PubMed ID: 35353100
[TBL] [Abstract][Full Text] [Related]
49. Postbiotics derived from
Zhang X; Li Y; Zhang C; Chi H; Liu C; Li A; Yu W
Food Funct; 2022 Oct; 13(21):11008-11020. PubMed ID: 36040437
[No Abstract] [Full Text] [Related]
50. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury.
Zahiri HR; Perrone EE; Strauch ED
Surgery; 2011 Sep; 150(3):480-9. PubMed ID: 21878234
[TBL] [Abstract][Full Text] [Related]
51. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
[TBL] [Abstract][Full Text] [Related]
52. Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice.
Liu HM; Chang ZY; Yang CW; Chang HH; Lee TY
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069256
[TBL] [Abstract][Full Text] [Related]
53. The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium.
Sarathy J; Detloff SJ; Ao M; Khan N; French S; Sirajuddin H; Nair T; Rao MC
Physiol Rep; 2017 May; 5(10):e13294. PubMed ID: 28554966
[TBL] [Abstract][Full Text] [Related]
54. CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p.
Ma D; Cao Y; Wang Z; He J; Chen H; Xiong H; Ren L; Shen C; Zhang X; Yan Y; Yan T; Guo F; Xuan B; Cui Z; Ye G; Fang JY; Chen H; Hong J
Inflamm Bowel Dis; 2019 Apr; 25(5):862-874. PubMed ID: 30615124
[TBL] [Abstract][Full Text] [Related]
55. [Effects of short chain fatty acid on barrier disruption of human intestinal epithelial cell induced by endotoxin/lipopolysaccharide and the related mechanism].
Feng YH; Huang YL; Wang P; Wang FJ
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):214-218. PubMed ID: 29690739
[No Abstract] [Full Text] [Related]
56. [Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model].
Zhang Y; Li J; Chi Y; Li M; Pan X; Zhang Q; He X; Liu Y
Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):434-8. PubMed ID: 26080824
[TBL] [Abstract][Full Text] [Related]
57. TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1.
Al-Sadi R; Guo S; Ye D; Ma TY
Am J Pathol; 2013 Dec; 183(6):1871-1884. PubMed ID: 24121020
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
Lapointe TK; Buret AG
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
[TBL] [Abstract][Full Text] [Related]
59. Obeticholic acid attenuates the intestinal barrier disruption in a rat model of short bowel syndrome.
Hou L; Wang H; Yan M; Cai Y; Zheng R; Ma Y; Tang W; Jiang W
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167221. PubMed ID: 38718845
[TBL] [Abstract][Full Text] [Related]
60. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo.
Clayburgh DR; Barrett TA; Tang Y; Meddings JB; Van Eldik LJ; Watterson DM; Clarke LL; Mrsny RJ; Turner JR
J Clin Invest; 2005 Oct; 115(10):2702-15. PubMed ID: 16184195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
